Halozyme Therapeutics | Salg Og Administrasjonskostnader



Selling And Administration Expenses Endring Dato
Acadia Pharmaceuticals USD 130.08M 3.21M 2024-12
Agios Pharmaceuticals USD 41.53M 10.17M 2025-03
Alnylam Pharmaceuticals USD 239.95M 55.39M 2025-03
Amarin USD 36.9M 1.64M 2024-09
Amgen USD 1.69B 191M 2025-03
Baxter International USD 703M 88M 2025-03
Cytokinetics USD 62.34M 5.69M 2024-12
DBV Technologies USD 6.24M 1.32M 2024-09
Eli Lilly USD 2.36B 62.3M 2025-03
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Indivior 132M 179M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
MannKind USD 23.97M 56K 2024-12
Pfizer USD 3.01B 1.27B 2025-03
United Therapeutics USD 170.1M 7.6M 2025-03



Halozyme Therapeutics Salg Og Administrasjonskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.